# Tenaya Therapeutics (TNYA) — Earnings

TNYA · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/tnya/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q3 2025 |
| Period end | Sep 30, 2025 |
| EPS actual | −$0.12 |
| EPS estimate | −$0.15 |
| EPS surprise | +19.03% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $0.00 |
| Reported | Nov 10, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1858848/000119312525273239/tnya-20250930.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q3 2025 | Nov 10, 2025 | −$0.15 | −$0.12 | 19.03% | — | — |
| Q2 2025 | Aug 6, 2025 | −$0.19 | −$0.14 | 25.89% | — | — |
| Q1 2025 | May 7, 2025 | −$0.19 | −$0.24 | -26.32% | — | — |
| Q4 2024 | Mar 10, 2025 | −$0.31 | −$0.28 | 9.91% | — | — |
| Q3 2024 | Nov 6, 2024 | −$0.37 | −$0.30 | 18.37% | — | — |
| Q2 2024 | Aug 8, 2024 | −$0.39 | −$0.34 | 13.20% | — | — |
| Q1 2024 | May 14, 2024 | −$0.42 | −$0.40 | 5.28% | — | — |
| Q4 2023 | Mar 18, 2024 | −$0.43 | −$0.40 | 7.79% | — | — |
| Q3 2023 | Nov 8, 2023 | −$0.47 | −$0.39 | 17.53% | — | — |
| Q2 2023 | Aug 9, 2023 | −$0.50 | −$0.45 | 10.59% | — | — |
| Q1 2023 | May 10, 2023 | −$0.56 | −$0.43 | 23.66% | — | — |
| Q4 2022 | Mar 8, 2023 | −$0.63 | −$0.61 | 3.44% | — | — |
| Q3 2022 | Nov 10, 2022 | −$0.66 | −$0.74 | -12.98% | — | — |
| Q2 2022 | Aug 10, 2022 | −$0.76 | −$0.69 | 8.61% | — | — |
| Q1 2022 | May 11, 2022 | −$0.65 | −$0.75 | -16.28% | — | — |
| Q4 2021 | Mar 23, 2022 | −$0.61 | −$0.63 | -4.13% | — | — |
| Q3 2021 | Nov 10, 2021 | −$0.49 | −$0.68 | -39.72% | — | — |
| Q2 2021 | Sep 8, 2021 | −$0.53 | −$13.26 | -2417.56% | — | — |

## Frequently Asked Questions

### When did Tenaya Therapeutics (TNYA) last report earnings?

Tenaya Therapeutics last reported on Nov 10, 2025, covering fiscal Q3 2025.

### Did TNYA beat earnings estimates?

Yes. Tenaya Therapeutics reported EPS of −$0.12 for Q3 2025 against a −$0.15 estimate — a 19.03% beat.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).